Type 2 & other diabetes

Dose–Response Associations of Intermittent Lifestyle Physical Activity Micropatterns and Incident Type 2 Diabetes

Diabetes CarePublished Prospective cohort study

Authors' conclusion

Among adults who do not engage in leisure-time exercise, accruing brief, intermittent bouts of moderate- to vigorous-intensity physical activity during day-to-day routines may be a promising strategy for prevention of type 2 diabetes.

Study context

Population
UK Biobank accelerometry substudy participants reporting no leisure-time exercise and without T2D at baseline; mean age 62.3 years, 56.4% female665 developed T2D
Participants
22,706 participants
Exposure
Daily duration and frequency of vigorous intermittent lifestyle physical activity (VILPA) and MV-ILPA vs none/lower
Outcome
Incident T2D (linked primary care, hospital and death records)
Follow-up
Average 7.9 years
Methodological detailsUK Biobank accelerometry substudy, wrist-worn accelerometers, multivariable-adjusted Fine-Gray subdistribution hazard models accounting for competing risks
  • UK Biobank accelerometry substudy
  • Wrist-worn accelerometers
  • Multivariable-adjusted Fine-Gray subdistribution hazard models accounting for competing risks

Main finding

As reported in the abstract

Incident T2D

Median VILPA 3.9 min/day vs no VILPA: lower risk of T2D

36%

Median MV-ILPA 25.3 min/day vs 3.9 min/day of MV-ILPA: lower risk of T2D

46%

Daily VILPA frequency: near-linear inverse association; 10.4 bouts/day (median) vs 0 bouts/day, HR

0.64 (0.51-0.81) (95% CI)

Daily MV-ILPA frequency: U-shaped pattern, risk reductions plateauing at ≈56 bouts/day, HR

0.54 (0.39-0.76) (95% CI)

Observational data: associations, not effects.

Original publication

Dose–Response Associations of Intermittent Lifestyle Physical Activity Micropatterns and Incident Type 2 Diabetes. Diabetes Care. Published 28 April 2026. doi:10.2337/dc25-3018

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.